Mineralys Therapeutics, Inc. Insider Selling: Brian Taylor Slingsby Trims Stake

A Form 4 filed with the SEC shows Brian Taylor Slingsby, Dir at Mineralys Therapeutics, Inc. (MLYS), sold 104,320 shares of company stock on 2026-09-22.

The transaction was executed at a price of $28.81 per share, for a total value of approximately $3.01 million.

Under SEC rules, corporate insiders — officers, directors, and holders of more than 10% of a company's shares — are required to report changes in their ownership within two business days of the transaction via Form 4.

Insider sales are common and can occur for reasons unrelated to a company's outlook, including scheduled trading plans, diversification, or personal financial planning.